Razin LS is a specialized combination medication aimed at effectively managing gastroesophageal reflux disease (GERD) and various gastrointestinal disorders. It combines Rabeprazole Sodium (EC) 20 mg with Levosulpiride (SR) 75 mg. Rabeprazole Sodium is a potent proton pump inhibitor (PPI) that decreases stomach acid production, thus providing relief from heartburn, swallowing difficulties, and chronic cough. It also aids in healing acid-induced damage in the stomach and esophagus, helping to prevent ulcers and potentially lowering the risk of esophageal cancer.Levosulpiride, a selective dopamine D2 receptor antagonist, enhances gastrointestinal motility. Its sustained release (SR) formulation ensures an extended therapeutic effect, alleviating symptoms like bloating, nausea, and gastric discomfort by facilitating the smooth passage of food through the digestive tract. Together, these ingredients in Razin LS offer a synergistic approach to relieving GERD and associated gastrointestinal symptoms, promoting overall digestive health and enhancing patient comfort.